Lv31
228 积分 2024-03-04 加入
Neurotransmitters in Neural Circuits and Neurological Diseases
1个月前
已完结
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
1个月前
已完结
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension
1个月前
已完结
JAK inhibitors, cardiovascular and thromboembolic events: what we know and what we would like to know
3个月前
已完结
Investigating the risk of deep vein thrombosis with JAK inhibitors: a disproportionality analysis using FDA Adverse Event Reporting System Database (FAERS)
3个月前
已完结
Editorial: Moving towards prognostic endoscopic scoring in IBD
4个月前
已完结
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
4个月前
已完结
Efficacy and safety of different oral prednisone tapering courses in adult anti‐NMDAR encephalitis: A multicenter prospective cohort study
5个月前
已完结
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
5个月前
已完结
Alternative Complement Pathway, Iptacopan, and IgA Nephropathy
6个月前
已完结
皖公网安备34019202002308
